Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Class I major histocompatibility complex antigens and tumor ploidy in breast and bronchogenic carcinomas.

Cancer detection and prevention - 1 Jan 1997

Redondo M, Concha A, Ruiz-Cabello F, Morell M, Esteban F, Talavera P, Garrido F

Abstract excerpt

We determined the frequency of expression of the major histocompatibility complex antigens HLA-A,B,C in tumor cells from 207 primary tumor lesions of breast and bronchogenic carcinomas, to see if the expression of theses antigens was linked with several clinicopathological parameters associated with tumor aggressivity, such as abnormal cellular DNA content. We compared tumor tissues with nonneoplastic tissues and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to DNA, Neoplasm

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Histocompatibility Antigens Class I

Share to Immunohistochemistry

Share to Lung Neoplasms

Share to Phenotype

Share to Ploidies

Source

Identifiers

PMID: 9043759

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Class I major histocompatibility complex antigens and tumor ploidy in breast and bronchogenic carcinomas.PMID 9043759Read ↗

Loss of HLA haplotype in lung cancer cell lines: implications for immunosurveillance of altered HLA class I/II phenotypes in lung cancer.Semantic proximity Read ↗

Genetic alterations of HLA-class II in ovarian cancer.Semantic proximity Read ↗

Can the HLA phenotype be used as a prognostic factor in breast carcinomas?Semantic proximity Read ↗

The biological consequences of altered MHC class I expression in tumours.Semantic proximity Read ↗

High frequency of HLA-B44 allelic losses in human solid tumors.Semantic proximity Read ↗

Phenotypic expression of histocompatibility antigens in human primary tumours and metastases.Semantic proximity Read ↗

High frequency of altered HLA class I phenotypes in laryngeal carcinomas.Semantic proximity Read ↗

HLA class I phenotype and genotype alterations in cervical carcinomas and derivative cell lines.Semantic proximity Read ↗

Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases.Semantic proximity Read ↗

High frequency of altered HLA class I phenotypes in invasive breast carcinomas.Semantic proximity Read ↗

The expression of histocompatibility-related leukocyte antigens in the pathway to cervical carcinoma.Semantic proximity Read ↗

Altered HLA expression by metastatic cervical carcinoma cells as a factor in impaired immune surveillance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.